← 홈

HER2+ 유방암

379개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 379개
ADCBiologicstaleCelldex TherapeuticsPhase 2

CDX-011 (CDX-011)

Breast Cancer · Metastatic gpNMB Over-expressing Triple

#MetastaticgpNMBOver-expressingTr#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 21%임상시험 13상태 ACTIVE
AntibodystaleHoffmann-La RochePhase 2

Selicrelumab (Selicrelumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 37.5%임상시험 13상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Z-endoxifen (Z-endoxifen)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 13상태 RECRUITING
ADCBiologicstaleAmbrx, Inc.Phase 3

ARX788 (ARX788)

HER2-positive, Metastatic Breast Cancer · Breast Neoplasms

#BreastNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 RECRUITING
ADCBiologicstaleShanghai Miracogen Inc.Phase 3

MRG002 (MRG002)

Advanced Breast Cancer; Metastatic Breast Cancer · Advanced or Metastatic Biliary Tract Can

#AdvancedorMetastaticBiliaryTract#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 ACTIVE
ADCBiologicstaleSuzhou Suncadia Biopharmaceutic…Phase 2

SHR-A2009 (SHR-A2009)

Advanced Breast Cancer; Metastatic Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 12상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

durvalumab (Imfinzi, Datopotamab deruxtecan + Durvalumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 56.5%임상시험 11상태 RECRUITING
ADCBiologicstaleShanghai JMT-Bio Inc.Phase 3

JSKN003 (JSKN003)

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
ADCBiologicstaleRochePhase 1

ado-trastuzumab emtansine (Kadcyla, T-DM1, PD-0332991 and T-DM1)

Advanced Breast Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 11상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant (Amcenestrant)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 42.3%임상시험 9상태 RECRUITING
ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 3

DP303c (DP303c)

HER2-positive Breast Cancer · Localized Advanced or Metastatic Gastric

#LocalizedAdvancedorMetastaticGas#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 9상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Lasofoxifene (Lasofoxifene)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 9상태 RECRUITING
ADCBiologicstaleCelldex TherapeuticsPreclinical

glembatumumab vedotin (glembatumumab vedotin)

Metastatic gpNMB Expressing Triple Negative Breast Cancer · Melanoma

#Melanoma#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 21%임상시험 9상태 ACTIVE
ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX22 (HLX22)

HER2-low Hormone Receptor Positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

[vic-]trastuzumab duocarmazine (SYD985, SYD985 ([vic-]trastuzumab duocarmazine))

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 27.8%임상시험 7상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 1

trastuzumab (Herceptin, SYD985, Vic-trastuzumab duocarmazine, Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

HER2-positive Breast Cancer; HER2 Low · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 27.8%임상시험 7상태 DISCONTINUED
ADCBiologicstaleHoffmann-La RochePhase 2

Atirmociclib (Atirmociclib)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSenhwa Biosciences, Inc.Phase 1

Pidnarulex (Pidnarulex)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING
ADCBiologicstaleAstraZenecaPreclinical

TDxd (TDxd)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 6상태 RECRUITING
ADCBiologicstaleSichuan Kelun-Biotech Biopharma…Phase 3

A166 (A166)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING

8 / 19 페이지

← 이전다음 →